Skip to main content
. Author manuscript; available in PMC: 2018 Jun 15.
Published in final edited form as: Eur J Pharmacol. 2017 Mar 18;805:25–35. doi: 10.1016/j.ejphar.2017.03.034

Fig. 5.

Fig. 5

Analysis of the newly synthesized proteins in A: Hs683 and, B: SKMEL-28 and C: NHDF cells by fluorescent assay. Positive control: cycloheximide 0.1 mM for 1 h. Data are expressed as the mean neosynthezised protein amounts normalized to the control (100%)±S.E.M. of the six replicates of one representative experiment. D: Dose-dependent evaluation of [35S]-methionine labeling in MDA-MB-231and NHDF cells after 80 min of treatment. CPMs were normalized to total protein.